AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site
* US$223 million expansion will add biologics capacity to AbbVie manufacturing network * Singapore manufacturing site to grow to more than 500 employees following expansion * Construction will commence immediately with facilities becoming operational in 2026 SINGAPORE, Jan. 26, 2024 /PRNews...
AbbVie Opens First Phase of its Global Manufacturing Facility in Singapore to Support the Growth of its Pipeline
- New site to expand the company's global operations for small molecule and biologics manufacturing - Marks AbbVie's first manufacturing presence in Asia - Singapore Minister for Trade and Industry, Mr. S. Iswaran attended the Opening Ceremony SINGAPORE, Sept. 29, 2016 /PRNewswire/ -- AbbVie (...
AbbVie Acquires Manufacturing Facility in Singapore; Further Expands Capabilities in Asia
NORTH CHICAGO, Ill., Nov. 21, 2014 /PRNewswire/ -- AbbVie Inc. (NYSE: ABBV) has acquired a small molecule active pharmaceutical ingredient (API) manufacturing site inSingapore's Tuas Biomedical Park. The facility will expand the company's global operations for small molecule and biologics manufac...
AbbVie Expands Manufacturing Presence with US$320 Million Investment in Singapore
NORTH CHICAGO, Ill., Feb. 6, 2014 /PRNewswire/ -- AbbVie Inc. (NYSE: ABBV) announces a US$320 million [approximately S$400 million] investment to establish operations in Singapore for small molecule and biologics active drug substance manufacturing. The completed facility will provide manufacturing...
AbbVie Celebrates Launch as New Biopharmaceutical Company with Employees, Patients
NEW YORK, Jan. 2, 2013 /PRNewswire/ -- AbbVie (NYSE:ABBV) today marks its launch as an independent biopharmaceutical company, with employees from more than 40 countries and patients joining AbbVie leaders as they ring the first opening bell of 2013 at the New York Stock Exchange. To view the mult...
Abbott Completes Separation of Research-Based Pharmaceuticals Business
- Major Milestone Marks 125th Anniversary of Company's Founding - Continues Diverse Healthcare Leadership in Diagnostics, Medical Devices, Nutrition and Branded Generic Pharmaceuticals - Set to Deliver Industry-Leading Growth, Expanding Margins and Strong Cash Flow - Businesses Aligned With...
